Advanced search
Publication Cover
Postgraduate Medicine Volume 124, 2012 - Issue 5
Submit an article Journal homepage
119
Views
6
CrossRef citations to date
0
Altmetric
Clinical Focus: ADHD, Depression, Pain, and Neurological Disorders

Combination Therapy Patterns and Predictors of ADHD in Commercially Insured and Medicaid Populations

Cliff Molife Global Health Outcomes, Eli Lilly and Company, Indianapolis, INCorrespondence[email protected]
, PhD, MPH,
Mark J. Bernauer Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN
, BS, RPH,
Amanda M. Farr Custom Data Analytics, Truven Health Analytics, Cambridge, MA
, MPH,
Virginia S. Haynes Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN
, PhD &
Doug Kelsey US Medical Division, Lilly USA, Indianapolis, IN
, MD
Pages 7-22 | Published online: 13 Mar 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cliff Molife, Virginia S. Haynes, Allen Nyhuis, Douglas E. Faries, Steve Gelwicks, Douglas K. Kelsey & Carlos I. Alatorre. (2018) Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine. Current Medical Research and Opinion 34:4, pages 619-632.
Read now
David B. Clemow, Oren W. Mason, Elias H. Sarkis, Dustin D. Ruff, Brad D. Berman, Craig L. Donnelly, Adelaide S. Robb, Donna S. Holland, Kory J. Schuh, Janet M. Barnes & Andre B. Araujo. (2015) Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review study. Expert Review of Neurotherapeutics 15:11, pages 1353-1366.
Read now

Articles from other publishers (4)

Azmi Nasser, Alisa R. Kosheleff, Joseph T. Hull, Tesfaye Liranso, Peibing Qin, Gregory D. Busse, Maurizio Fava, Vladimir Maletic, Jonathan Rubin & Frank Lopez. (2021) Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended‐release in children and adolescents with attention‐deficit/hyperactivity disorder. International Journal of Clinical Practice 75:8.
Crossref
Robert L. Findling, Shawn A. Candler, Azmi F. Nasser, Stefan Schwabe, Chungping Yu, Jennie Garcia-Olivares, Welton O’Neal & Jeffrey H. Newcorn. (2021) Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status. CNS Drugs 35:6, pages 643-653.
Crossref
Shamia L. Faison, Nicholas Fry, Toyin Adewole, Oyinkansola Odebo, Zhao Wang, Vladimir MaleticAzmi Nasser. (2021) Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults. Journal of Clinical Psychopharmacology 41:2, pages 155-162.
Crossref
Shamia L. Faison, Nicholas Fry, Toyin Adewole, Oyinkansola Odebo, Stefan Schwabe, Zhao Wang, Vladimir Maletic & Azmi Nasser. (2020) Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults. Clinical Drug Investigation 41:2, pages 149-159.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.